Aerie Pharmaceuticals AERI
$ 15.25
0.0%
Quarterly report 2022-Q3
added 12-23-2023
Country |
USA |
IPO year |
2013 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Dr. Vicente Anido |
Employees in the company |
380 |
Shares |
46.3 M |
Market Cap[1] |
$ 754 M |
EBITDA (LTM) |
$ -109 M |
P/E (LTM) |
-5.89 |
P/S (LTM) |
6.89 |
EPS (LTM) |
-2.59 |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.